Cash shell Antisoma continues to seek a new business.
Antisoma has a net asset value of £12.3m. At 1.73p a share, the former biotech firm is valued at £11m. There was cash in the bank of £13.6m at the end of 2011 but the NAV includes £4.33m of preference shares.
Administration costs have been reduced.
ORA (Guernsey) Ltd owns 29.1% of Antisoma, which switched to AIM on 11 January.
Download the latest AIM Journal from http://www.hubinvest.com/AIMPDFMarch2012_30.pdf
© 2007 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Natural pesticides developer Eden Research says that the EU has approved the three main active ingredients in its main product.
Increased sales of LED lighting products has boosted revenues at Advanced Power Components (APC) but the profit benefits are only starting to show through.
London-based residential property agency M Winkworth has signed a master franchise agreement for India.
New products will help to accelerate the growth of tracking and security products developer Starcom.